Works by Kotsiubinskaya, Yulia V.

Results: 1
    1

    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiD<sup>TM</sup>II) for the treatment of cognitive impairment after mild traumatic brain injury.

    Published in:
    PLoS ONE, 2025, v. 20, n. 7, p. 1, doi. 10.1371/journal.pone.0310229
    By:
    • Pilipenko, Pavel I.;
    • Ivanova, Anna A.;
    • Kotsiubinskaya, Yulia V.;
    • Grigoryeva, Vera N.;
    • Khrulev, Alexey Y.;
    • Skorokhodov, Anatoly V.;
    • Gavrik, Maxim M.;
    • Mkrtchan, Nona N.;
    • Majdan, Marek;
    • Valkovic, Peter;
    • Rabarova, Daria;
    • Barker-Collo, Suzanne;
    • Jones, Kelly;
    • Feigin, Valery L.
    Publication type:
    Article